EUDAW
EUDA Health Holdings LimitedNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
0.56
52W High
$0.18
52W Low
$0.02
50-Day MA
$0.00
200-Day MA
$0.00
Dividend Yield
—
Profit Margin
-40.70%
Forward P/E
—
PEG Ratio
—
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is an innovative biotechnology company focused on creating advanced therapies for dermatological and chronic health conditions. Leveraging scientific excellence and technological integration, the firm aims to meet significant unmet medical needs through a robust pipeline of transformative products. With an experienced leadership team dedicated to improving patient outcomes, EUDA is strategically positioned to seize growth opportunities in the dynamic healthcare sector.
Fundamentals
| Revenue (TTM) | $6.82M |
| Gross Profit (TTM) | $2.99M |
| EBITDA | $-2.24M |
| Operating Margin | -34.80% |
| Return on Equity | 0.00% |
| Return on Assets | -89.30% |
| Revenue/Share (TTM) | $3.65 |
| Book Value | $-2.25 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 78.90% |
| Shares Outstanding | 0 |
| Float | $1.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 5/25/2026